Bank of New York Mellon’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.75M | Buy |
|
|||||
|
2025
Q2 | $1.46M | Buy |
|
|||||
|
2025
Q1 | $996K | Sell |
|
|||||
|
2024
Q4 | $1.55M | Buy |
|
|||||
|
2024
Q3 | $5.54M | Sell |
|
|||||
|
2024
Q2 | $5.41M | Buy |
|
|||||
|
2024
Q1 | $6.6M | Buy |
|
|||||
|
2023
Q4 | $3.76M | Sell |
|
|||||
|
2023
Q3 | $4.6M | Buy |
|
|||||
|
2023
Q2 | $4.08M | Sell |
|
|||||
|
2023
Q1 | $5.66M | Buy |
|
|||||
|
2022
Q4 | $4.51M | Buy |
|
|||||
|
2022
Q3 | $2.8M | Buy |
|
|||||
|
2022
Q2 | $1.29M | Buy |
|
|||||
|
2022
Q1 | $2.53M | Buy |
|
|||||
|
2021
Q4 | $2.71M | Buy |
|
|||||
|
2021
Q3 | $1.7M | Buy |
|
|||||
|
2021
Q2 | $1.63M | Sell |
|
|||||
|
2021
Q1 | $2.63M | Sell |
|
|||||
|
2020
Q4 | $3.02M | Buy |
|
|||||
|
2020
Q3 | $699K | Sell |
|
|||||
|
2020
Q2 | $682K | Buy |
|